Artiva Biotherapeutics ARTV
NASDAQ ARTV
$6.20 -0.29 (-4.47%)
At close: Oct 22, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Change in Receivables (2023 - 2024)

Updated

Artiva Biotherapeutics' Change in Receivables was -$569,000 in Q4 2024, compared with -$1.1 million a year earlier.

Analysis

Artiva Biotherapeutics (ARTV) Change in Receivables (2023 - 2024) Analysis & Trends

For FY2024, Change in Receivables at Artiva Biotherapeutics came in at -$1.03 million.

  • In earlier years, Change in Receivables was $510,000 in FY2023.
  • Quarterly Change in Receivables has moved between -$1.1 million (Q4 2023) and -$80,000 (Q3 2023) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -188.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 1.37 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 333.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Artiva Biotherapeutics 244.36 Mn -105.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -569,000.00
Jun 30, 2024 -250,000.00
Mar 31, 2024 -215,000.00
Dec 31, 2023 -1.10 Mn
Sep 30, 2023 -80,000.00
API Access

Artiva Biotherapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ARTV&period=max&api_key=YOUR_API_KEY